Labiotech.eu

Biotech and biopharma companies choose names that cluster around certain letters in the alphabet - here's what they are, and why it happens. The post The Naming Patterns Behind 12,000 Biotech Companies appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is…

This week we preview the BIO International Convention, starting next week in San Diego. The post BIO International Convention 2026: practical advice from former Evotec CEO Werner Lanthaler appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly pro…

We have curated a list of in vivo CAR T biotechs in preclinical and clinical stages that you should keep an eye out for. The post Eight in vivo CAR T biotechs to follow closely appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Exc…

Explore how viral vector CDMOs improve late-stage cell and gene therapy success by reducing risk, variability, and complexity. The post Viral vector production: How CDMOs influence late-stage development success appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/o…

Find out more about the wave of biotech rebranding and why a growing number of companies are choosing this path to start afresh. The post New names, new narratives: Why biotechs decide to rebrand appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is stric…

Not so long ago, DIY biology mostly meant extracting DNA from strawberries or growing mold in a petri dish for a school science project. Those experiments are still around, but the world of amateur biology has evolved considerably over the past decade.  Today, a growing network of community biology labs and citizen scientists is making biotechnology more […] The post DIY biology experiments: how …

Today we’re diving into the world of corticosteroids and hormonal therapies, essential APIs that treat everything from asthma and autoimmune diseases to diabetes and endocrine disorders. The post Advancing corticosteroids and hormonal therapies for supply and scale appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without expres…

Discover Daiichi Sankyo's pipeline strategy, including how it aims to become a top-five global oncology company by 2035. The post How Daiichi Sankyo aims to become a top five oncology player by 2035 appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is st…

Find out about some early-stage technologies in neurology that aim to go beyond amyloid, dopamine, and what has dominated the field. The post Beyond amyloid and dopamine: emerging technologies reshaping neurology appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/…

Spain is emerging as a European pharma and biotech hub, driven by scientific excellence, clinical trial leadership, innovation, and investor appeal. The post Pharma in Spain: why global investors and innovators are moving in appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s…

There were seven multibillion-dollar acquisitions that occurred in May 2026, although it was a quieter month on the biotech deals front. The post Top biotech deals in May 2026 appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Exce…

Discover 8 key oncology deals that have been made so far in 2026, spotlighting where industry leaders are betting big. The post Eight oncology deals in 2026 spotlight where industry leaders are betting big appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owne…

Discover 8 key oncology deals that have been made so far in 2026, spotlighting where industry leaders are betting big. The post Eight oncology deals in 2026 spotlight where industry leaders are betting big appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owne…

Today we are delighted to welcome back a very special guest: Joachim Eeckhout, the co-founder of Labiotech, co-owner of Knowbio, and founder of The Science Marketer. The post Episode 200 Special: Joachim Eeckhout on building Labiotech and the future of biotech media appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without expre…

Labiotech heard from experts about the major trends and highlights in cancer care at ASCO 2026. The post Highlights of ASCO 2026: how is cancer care evolving? appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links ma…

We look at how rising acquisitions in the life science industry are being driven by patent cliffs. The post Surge in M&As driven by patent expirations appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be use…

Isomorphic Labs, Apogee Therapeutics, and Avalo Therapeutics bagged the biggest biotech funding rounds overall in May 2026. The post The biggest biotech funding rounds in May 2026 appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. …

Explore the future of cell and gene therapies in China as it adopts a new piece of regulation that might change strategies. The post What China’s new CGT rules mean for biotech business appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohib…

Find out about how biotech companies are trying to address the limits the first generation of WEE1 inhibitors faced. The post Can WEE1 inhibitors finally make replication stress druggable? appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly pro…

Today we welcome Dr. Daniel Vitt, CEO of Immunic Therapeutics. With World MS Day tomorrow 30th of May, this is the perfect moment to focus on multiple sclerosis. The post World MS Day Special: Immunic reveals new hope for progressive MS appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from…